Pharmaceutical stocks high-quality shares are: Jianfan Biologicals, Myriad Medical, WuXi Kangde, Zhaoyan New Drugs, AiDe Biologicals, Oppo KangVision, Dabo Medical, JianYou shares, DashenLin, KelaiYing.
1, Jianfan biological (300529): blood perfusion related products, China's blood perfusion field leading enterprises. Revenue and net profit for two consecutive years to maintain more than 32% growth, return on net assets of about 24 %, gross margin of about 84%, dynamic price-earnings ratio of 46 times, total market value of 24.3 billion.
2, Myriad Medical (300760): leading medical device stocks. Revenue and net profit continued high growth, return on net assets of 28% to 47% between the gross profit margin of 66% dynamic price-earnings ratio of 44 times, total market capitalization of 177.1 billion. (Foreign to A-share listing)
3, WuXi KangDe (603259): CRO industry leading stock staring macro. Revenue and net profit continued high growth, return on net assets between 21 a 29%, gross profit margin of 39% or so, dynamic price-earnings ratio of 59 times, total market value of 92.7 billion. (Foreign to hole transport A shares listed)
4, Zhaoyan new drugs (603127): 20 % or so, gross profit margin of 53% or so of the pharmaceutical preclinical research services stock, the domestic industry leader in the field of security assessment. Revenue and net profit continued high growth, return on net assets dynamic price-earnings ratio of 153 times, total market capitalization of 7.3 billion.
5, Aide Bio (300685): tumor precision medicine molecular diagnostics leading stocks. Revenue and net profit for three consecutive years to maintain more than 30% growth, return on net assets of about 20%, Mauna then beam rate of about 91%, dynamic price-earnings ratio of 59 times, total market capitalization of 7.7 billion.
6, OpusCare (300595): domestic OK mirror leading enterprises. Revenue and net profit for many years to maintain more than 30% growth, return on net assets between 21% and 38%, gross profit margin of 77% or so, the dynamic price-earnings ratio of 71 times, total market capitalization of 14.4 billion.
7, Dabo medical (002901): medical high health topic stocks, orthopedic implant class domestic leader. Revenue and net profit for three consecutive years to maintain more than 16% growth, return on net assets of more than 28%, gross profit margin of 82% or so, the dynamic price-earnings ratio of 40 times, total market capitalization of 13.4 billion.
8, Jianyou shares (603707): pharmaceutical raw materials, preparations, the domestic injection of internationalization pioneer enterprises. Revenue and net profit for three consecutive years to maintain more than 32% growth, return on net assets of about 19%, gross profit margin of about 47%, dynamic price-earnings ratio of 31 times, total market value of 19 billion.
9, Dazanlin (603233): South China's leading pharmaceutical chain. Revenue and net profit for two consecutive years to maintain double-digit growth, return on net assets of 18 37% of the dynamic price-earnings ratio of 31 times, total market value of 22.8 billion.
10, Kelaiying (002821): domestic COMO leading enterprises. Revenue and net profit